# To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture

> **NCT02675153** · NA · UNKNOWN · sponsor: **The Second Hospital of Nanjing Medical University** · enrollment: 15 (estimated)

## Conditions studied

- Crohn's Diseases

## Interventions

- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT02675153
- **Lead sponsor:** The Second Hospital of Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04-01
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675153, "To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02675153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*